Based on whole-exome sequencing to explore the rule of Herceptin and TKI resistance in breast cancer patients

Abstract Background Breast cancer is the second leading cause of cancer-related death in women, and drug resistance during treatment is a major challenge. However, the mechanisms underlying drug resistance are not fully understood. Here we applied whole-exome sequencing (WES) to clarify resistant ru...

詳細記述

書誌詳細

出版年:	BMC Medical Genomics
主要な著者:	Liantao Guo, Hong Cheng, Jianhua Liu, Weikang Shao, Lan Luo, Weijie Zheng, Shengrong Sun, Deguang Kong, Chuang Chen
フォーマット:	論文
言語:	英語
出版事項:	BMC 2024-01-01
主題:	Breast cancer WES Herceptin resistance TKI resistance Immunotherapy
オンライン･アクセス:	https://doi.org/10.1186/s12920-023-01762-x